TIcaGrEloR and ABSORB Bioresorbable Vascular Scaffold Implantation for Recovery of Vascular Function After Successful Chronic Total Occlusion Recanalization

NCT02211066 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

59

Enrollment

OTHER

Sponsor class

Conditions

Patients Who Are Scheduled to Undergo a PCI (Percutaneous Coronary Intervention) for CTO (Chronic Total Occlusion)

Interventions

DRUG: Clopidogrel
DRUG: Ticagrelor

Sponsor

Hospital Clinic of Barcelona

Collaborators

[object Object]